Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1, implications for early stratification from a multicenter registry

  • Lorca Gutiérrez, Rebeca
  • Moliner-Abós, Carles|||0000-0002-9264-5804
  • Alen, Alberto
  • De Frutos, Fernando|||0000-0003-4350-3217
  • Peña-Peña, María Luisa
  • Villacorta, Eduardo|||0000-0003-0486-1740
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Zorio, Esther|||0000-0003-3608-4210
  • Larrañaga-Moreira, José M.|||0000-0002-8370-5158
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • García-Hernández, Soledad|||0000-0003-2547-685X
  • Palomino-Doza, Julián
  • Soriano-Amores, Marc|||0000-0002-6000-1828
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Báez-Ferrer, Néstor
  • Martínez-Gimeno, Aaron
  • Bermúdez-Jiménez, José
  • Limeres, Javier
  • Tiron, Coloma
  • Cabrera-Romero, Eva
  • Espinosa, María Angeles
  • Piqueras-Flores, Jesús
  • Morís, Germán|||0000-0001-7608-2194
  • Carrillo-Mora, Lidia María
  • Syris, Petros
  • Alvarez-Velasco, Rut
  • Gimeno-Blanes, Juan Ramón
DM1 is an autosomal dominant disorder caused by unstable CTG repeats that expand over lifetime and in successive generations, contributing to genetic anticipation. Cardiac conduction abnormalities (CCAs) are a major source of morbidity and premature death in DM1, yet the influence of age at diagnosis, generation, and CTG repeat length on the timing and progression of cardiac involvement remains poorly defined. This multicentric retrospective study included 549 adult DM1 patients from 16 hospitals in Spain. The primary composite endpoint comprised significant CCAs, device implantation, malignant ventricular arrhythmias and cardiac syncope. Patients were stratified by age-at-diagnosis (.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epigenetic study of cohort of monozygotic twins with hypertrophic cardiomyopathy due to MYBPC3 (Cardiac Myosin-Binding Protein C)

  • Peñarroya, Alfonso
  • Lorca, Rebeca
  • Rodríguez Reguero, José Julián
  • Gómez, Juan
  • Avanzas, Pablo
  • Tejedor, Juan Ramón
  • Fernández, Agustín F.
  • Fraga, Mario F.
[Background]: Hypertrophic cardiomyopathy is an autosomal dominant cardiac disease. The mechanisms that determine its variable expressivity are poorly understood. Epigenetics could play a crucial role in bridging the gap between genotype and phenotype by orchestrating the interplay between the environment and the genome regulation. In this study we aimed to establish a possible correlation between the peripheral blood DNA methylation patterns and left ventricular hypertrophy severity in patients with hypertrophic cardiomyopathy, evaluating the potential impact of lifestyle variables and providing a biological context to the observed changes., [Methods and results]: Methylation data were obtained from peripheral blood samples (Infinium MethylationEPIC BeadChip arrays). We employed multiple pair-matched models to extract genomic positions whose methylation correlates with the degree of left ventricular hypertrophy in 3 monozygotic twin pairs carrying the same founder pathogenic variant (MYBPC3 p.Gly263Ter). This model enables the isolation of the environmental influence, beyond age, on DNA methylation changes by removing the genetic background. Our results revealed a more anxious personality among more severely affected individuals. We identified 56 differentially methylated positions that exhibited moderate, proportional changes in methylation associated with left ventricular hypertrophy. These differentially methylated positions were enriched in regions regulated by repressor histone marks and tended to cluster at genes involved in left ventricular hypertrophy development, such as HOXA5, TRPC3, UCN3, or PLSCR2, suggesting that changes in peripheral blood may reflect myocardial alterations., [Conclusions]: We present a unique pair-matched model, based on 3 monozygotic twin pairs carrying the same founder pathogenic variant and different phenotypes. This study provides further evidence of the pivotal role of epigenetics in hypertrophic cardiomyopathy variable expressivity., This work was supported by Health Institute Carlos III cofunding El Fondo Europeo de Desarrollo Regional- FEDER (PI22/00705 to J.G. and R.L.; PI18/01527 and PI21/01067 to M.M.F. and A.F.F.; COV00624 to J.R.T. and M.M.F.), the Spanish Association Against Cancer (PROYE18061FERN to M.M.F.), the Asturias Government (PCTI) cofunding 2018- 2023/FEDER (IDI/2018/146 and IDI/2021/000077 to M.M.F.), and the European Commission NextGenerationEU, through Consejo Superior de Investigaciones Científicas’s Global Health Platform (PTI Salud Global), and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (SGL2021- 03- 39 and SGL2021- 03- 040). A.P. is supported by the Health Institute Carlos III (FI19/00085)., Peer reviewed